Legislators
Bills
Statements
Lobbying
Travel
Searching...- Bills
- H.R.971
H.R.971: Orphan Product Extensions Now Accelerating Cures and Treatments Act of 2015
About This Bill
- This bill was introduced in the 114th Congress
- This bill is primarily about health
- Introduced Feb. 13, 2015
- Latest Major Action Feb. 20, 2015
- See the one similar bills introduced in other congresses.
Bill Sponsor
Bill Cosponsors
21 (5 Democrats, 16 Republicans)
Bill Summary
Orphan Product Extensions Now Accelerating Cures and Treatments Act of 2015 Amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to extend by six months the exclusivity period for an approved drug or biological product when the product is additionally approved to prevent, diagnose, or treat a new indication that is a rare disease or condition (also known as an “orphan disease”). Allows the FDA to...
(Source: Library of Congress)
What Lawmakers Are Saying About This Bill
Bill Actions
| Date | Description |
|---|---|
| Feb. 20, 2015 |
Referred to the Subcommittee on Health.
|
| Feb. 13, 2015 |
Referred to the House Committee on Energy and Commerce.
|
| Feb. 13, 2015 |
Introduced in the House by Gus Bilirakis (R-Fla.) |